US regulators OK new COVID-19 shot option from Novavax

By LAURAN NEERGAARD
AP Medical Writer

The U.S. is getting another COVID-19 vaccine choice. The Food and Drug Administration on Wednesday cleared Novavax shots for adults. It’s a more traditional type of vaccine than the Pfizer and Moderna shots already used to protect most Americans. Still, millions of adults haven’t yet gotten vaccinated even this late in the pandemic. Experts expect at least some of them to roll up their sleeves for the more conventional technology. The Centers for Disease Control still must recommend how to use the Novavax vaccine before shots begin. The U.S. has bought 3.2 million doses.